Strategic Delay Costs Novartis Its Cross-Examination Rights

Banner with text “Tactical Delay Proves Costly for Novartis” beside a clock and wooden blocks spelling DELAY on an orange background Featured image for article: Strategic Delay Costs Novartis Its Cross-Examination Rights

The Delhi High Court dismissed Novartis’s writ petitions, ruling it had waived cross-examination by opting for rebuttal evidence. The Controller’s orders were upheld, with the patent already revoked days earlier.

Read more about Strategic Delay Costs Novartis Its Cross-Examination Rights

Divisional Applications cannot exceed scope of Parent Application: Delhi High Court

The Delhi High Court has clarified that divisional applications under the Patents Act must not exceed the scope of the parent application and require plurality of inventions in the original claims. This decision reinforces the primacy of claims in determining the scope of patent protection.

Read more about Divisional Applications cannot exceed scope of Parent Application: Delhi High Court

Tribunals Reforms Ordinance 2021 and amendments to the Patents Act, 1970

The Tribunals Reforms Ordinance 2021 has brought significant changes to the Patents Act, 1970, by eliminating the Appellate Board and shifting its functions to the High Court. These amendments aim to centralise patent dispute resolution and enhance judicial efficiency in India.

Read more about Tribunals Reforms Ordinance 2021 and amendments to the Patents Act, 1970